Bicara Therapeutics Inc. Common Stock
BCAX •
Buy Open
Signal type
Buy
Status
Open
Open Price
$21.05
Stop Loss
$18.49
Performance
9.17%
Days Open
14
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 1, 2026
Open Price $21.05
Stop Loss $18.49
Timespan Day
Company Profile
Name Bicara Therapeutics Inc. Common Stock
Ticker BCAX
Market Cap $501.73M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $22.98
List Date Sep 13, 2024
Description
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
Website Open Company Website